| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.48 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |